Description: Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Home Page: www.genmab.com
Kalvebod Brygge 43
Copenhagen,
1560
Denmark
Phone:
45 70 20 27 28
Officers
| Name | Title |
|---|---|
| Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, Pres & CEO |
| Mr. Anthony Pagano | Exec. VP & CFO |
| Mr. Anthony Mancini | Exec. VP & COO |
| Dr. Judith V. Klimovsky M.D. | Exec. VP & Chief Devel. Officer |
| Dr. Tahamtan Ahmadi | Exec. VP, Chief Medical Officer & Head of Experimental Medicines |
| Dr. Mijke Zachariasse Ph.D. | Director of Protein Production & Chemist and Non-Independent Director |
| Dr. Rima Bawarshi Nassar Ph.D. | VP, Head of Global Regulatory Affairs ? Oncology & Non-Independent Director |
| Mr. Peter Ros | Sr. Director of Fin. & Accounting |
| Mr. Andrew Carlsen | Sr. Director, VP & Head of Investor Relations |
| Ms. Birgitte Stephensen M.Sc. | Exec. VP & Chief Legal Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 35.0877 |
|---|---|
| Trailing PE: | 34.6535 |
| Price-to-Book MRQ: | 7.9422 |
| Price-to-Sales TTM: | 2.4516 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1560 |